Literature DB >> 9281452

Differential protein expression and subcellular distribution of TGFbeta1, beta2 and beta3 in cardiomyocytes during pressure overload-induced hypertrophy.

J M Li1, G Brooks.   

Abstract

The transforming growth factor beta (TGFbeta) superfamily plays an important role in the myocardial response to hypertrophy. We have investigated the protein expression of TGFbeta1, beta2 and beta3 in left ventricular tissue, and determined their subcellular distribution in myocytes by immunoblotting and immunocytochemistry during the development of left ventricular hypertrophy (LVH), using isoform specific antibodies to TGFbeta1, beta2 and beta3. LVH was produced in rats by aortic constriction (AC) and LV tissue was obtained at days (d)0, 1, 3, 7, 14, 21 and 42 following operation. Compared with age matched sham-operated controls (SH), TGFbeta1 levels in LV tissue of AC rats increased significantly from d1-d14 (P<0.03) concomitant with the adaptive growth of LV tissue. In contrast, TGFbeta3 levels decreased in LV tissue of AC rats from d3 post-operation (significant from d14-d42, P<0.03). No significant difference in TGFbeta2 levels were observed from SH and AC rats after operation. Antibodies to TGFbeta1 stained intercalated disks, sarcolemmal membranes and cytoplasm, but not nuclei, of cardiomyocytes on LV sections from untreated and SH rats. However, a trans-localisation of TGFbeta1 to the nuclei of cardiomyocytes was observed in AC hearts. Antibodies to TGFbeta3 stained T tubules, cytoplasm and the nuclei of cardiomyocytes from untreated and SH rats. However, by d7 post-AC operation, TGFbeta3 expression was lost rapidly from nuclei of cardiomyocytes followed by a reduction in total TGFbeta3 immunofluorescence in myocytes. Antibodies to TGFbeta2 stained sarcolemmal membranes of cardiomyocytes from both SH and AC rats without significant difference between groups. Thus, the differential pattern of protein expression and subcellular distribution of TGFbeta1, beta2 and beta3 in myocytes during the development of LVH suggests that these molecules play different roles in the response of cardiomyocytes to LVH.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9281452     DOI: 10.1006/jmcc.1997.0457

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  15 in total

1.  Pharmacological inhibition of TGFβ receptor improves Nkx2.5 cardiomyoblast-mediated regeneration.

Authors:  Wen-Pin Chen; Yuan-Hung Liu; Yi-Jin Ho; Sean M Wu
Journal:  Cardiovasc Res       Date:  2014-10-31       Impact factor: 10.787

2.  Cardiac Tissue Chips (CTCs) for Modeling Cardiovascular Disease.

Authors:  Aaron J Rogers; Jessica M Miller; Ramaswamy Kannappan; Palaniappan Sethu
Journal:  IEEE Trans Biomed Eng       Date:  2019-03-18       Impact factor: 4.538

Review 3.  Transforming growth factor (TGF)-β signaling in cardiac remodeling.

Authors:  Marcin Dobaczewski; Wei Chen; Nikolaos G Frangogiannis
Journal:  J Mol Cell Cardiol       Date:  2010-11-06       Impact factor: 5.000

Review 4.  [Pathophysiologic significance of growth factors and new therapeutic concepts in cardiovascular disease].

Authors:  S Rosenkranz; M Böhm; A Kazlauskas
Journal:  Med Klin (Munich)       Date:  1999-09-15

5.  Qiliqiangxin improves cardiac function and attenuates cardiac remodelling in doxorubicin-induced heart failure rats.

Authors:  Xutao Sun; Guozhen Chen; Ying Xie; Deyou Jiang; Jieru Han; Fei Chen; Yunjia Song
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

6.  Phosphoprotein abundance changes in hypertensive cardiac remodeling.

Authors:  Kumar Kotlo; Keven R Johnson; Jean M Grillon; David L Geenen; Pieter deTombe; Robert S Danziger
Journal:  J Proteomics       Date:  2012-05-31       Impact factor: 4.044

7.  Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart.

Authors:  DeLisa Fairweather; Sylvia Frisancho-Kiss; Susy A Yusung; Masheka A Barrett; Sarah E Davis; Shannon J L Gatewood; Dolores B Njoku; Noel R Rose
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

8.  Stretch-induced paracrine hypertrophic stimuli increase TGF-beta1 expression in cardiomyocytes.

Authors:  Annemieke J E T van Wamel; Cindy Ruwhof; Lizette J M van der Valk-Kokshoorn; Peter I Schrier; Arnoud van der Laarse
Journal:  Mol Cell Biochem       Date:  2002-07       Impact factor: 3.396

9.  Low-dose Dasatinib Ameliorates Hypertrophic Cardiomyopathy in Noonan Syndrome with Multiple Lentigines.

Authors:  Jae-Sung Yi; Sravan Perla; Yan Huang; Kana Mizuno; Frank J Giordano; Alexander A Vinks; Anton M Bennett
Journal:  Cardiovasc Drugs Ther       Date:  2021-03-10       Impact factor: 3.947

10.  Achievement of a target dose of bisoprolol may not be a preferred option for attenuating pressure overload-induced cardiac hypertrophy and fibrosis.

Authors:  Shizhao Xiang; Ning Zhang; Zheng Yang; Zhouyan Bian; Yuan Yuan; Qizhu Tang
Journal:  Exp Ther Med       Date:  2016-08-04       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.